trial · primary record
Ramantamig
Multiple Myeloma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1000 |
| Primary completion | 2035-02-02 |
| Primary endpoint | Progression-Free Survival (PFS) |
| Registry ID | NCT07665450 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:56:17.607Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07665450
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Ramantamig · compound